日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In Vitro Analysis of the Differentiation Capacity of Postmortally Isolated Human Chondrocytes Influenced by Different Growth Factors and Oxygen Levels

体外分析不同生长因子和氧气水平对死后分离的人类软骨细胞分化能力的影响

Jonitz-Heincke, Anika; Klinder, Annett; Boy, Diana; Salamon, Achim; Hansmann, Doris; Pasold, Juliane; Buettner, Andreas; Bader, Rainer

Devitalisation of human cartilage by high hydrostatic pressure treatment: Subsequent cultivation of chondrocytes and mesenchymal stem cells on the devitalised tissue

利用高静水压处理使人软骨失活:随后在失活组织上培养软骨细胞和间充质干细胞

Hiemer, B; Genz, B; Jonitz-Heincke, A; Pasold, J; Wree, A; Dommerich, S; Bader, R

Co-Culture of S. epidermidis and Human Osteoblasts on Implant Surfaces: An Advanced In Vitro Model for Implant-Associated Infections

表皮葡萄球菌和人类成骨细胞在植入物表面的共培养:植入物相关感染的先进体外模型

Sarah Zaatreh, Katharina Wegner, Madlen Strauß, Juliane Pasold, Wolfram Mittelmeier, Andreas Podbielski, Bernd Kreikemeyer, Rainer Bader

Positive impact of IGF-1-coupled nanoparticles on the differentiation potential of human chondrocytes cultured on collagen scaffolds.

IGF-1偶联纳米颗粒对胶原支架上培养的人类软骨细胞分化潜能的积极影响

Pasold Juliane, Zander Kathleen, Heskamp Benjamin, Grüttner Cordula, Lüthen Frank, Tischer Thomas, Jonitz-Heincke Anika, Bader Rainer

Comparative in vitro study on magnetic iron oxide nanoparticles for MRI tracking of adipose tissue-derived progenitor cells

磁性氧化铁纳米粒子对脂肪组织来源的祖细胞进行 MRI 追踪的体外比较研究

Annika Kasten, Cordula Grüttner, Jens-Peter Kühn, Rainer Bader, Juliane Pasold, Bernhard Frerich

Surface modifications of dental ceramic implants with different glass solder matrices: in vitro analyses with human primary osteoblasts and epithelial cells

使用不同玻璃焊料基质对牙科陶瓷植入物进行表面改性:对人类原代成骨细胞和上皮细胞进行体外分析

Jana Markhoff, Enrico Mick, Aurica Mitrovic, Juliane Pasold, Katharina Wegner, Rainer Bader

Medical student self-efficacy, knowledge and communication in adolescent medicine

医学生在青少年医学领域的自我效能、知识和沟通能力

Woods, Jennifer L; Pasold, Tracie L; Boateng, Beatrice A; Hense, Devon J

Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone--a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

东德血液肿瘤研究组 (OSHO) 的一项随机 III 期研究表明,与美法仑和泼尼松治疗相比,苯达莫司汀和泼尼松治疗新诊断的多发性骨髓瘤患者可获得更高的完全缓解率、更长的治疗失败时间和更好的生活质量。

Pönisch, W; Mitrou, P S; Merkle, K; Herold, M; Assmann, M; Wilhelm, G; Dachselt, K; Richter, P; Schirmer, V; Schulze, A; Subert, R; Harksel, B; Grobe, N; Stelzer, E; Schulze, M; Bittrich, A; Freund, M; Pasold, R; Friedrich, Th; Helbig, W; Niederwieser, D

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

苯达莫司汀、长春新碱和泼尼松(BOP)与环磷酰胺、长春新碱和泼尼松(COP)治疗晚期惰性非霍奇金淋巴瘤和套细胞淋巴瘤的疗效比较:一项随机 III 期试验的结果(OSHO# 19)

Herold, M; Schulze, A; Niederwieser, D; Franke, A; Fricke, H J; Richter, P; Freund, M; Ismer, B; Dachselt, K; Boewer, C; Schirmer, V; Weniger, J; Pasold, R; Winkelmann, C; Klinkenstein, C; Schulze, M; Arzberger, H; Bremer, K; Hahnfeld, S; Schwarzer, A; Müller, C; Müller, Chr